Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-025216

Chief Regulatory Officer gave up 2,509 shares (to pay taxes)

  • Chief Regulatory Officer acquired 8,334 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Puri Raj K. · Chief Regulatory Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-14 Exercise or conversion : show line 1 in the form +8,334 203,761 D
2025-03-14 Shares withheld for taxes : show line 2 in the form −2,509 $3.59 $9,007 201,252 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-14 Exercise or conversion : show line 3 in the form Restricted Stock Units −8,334 0 D
Loading xslF345X05/tm259584-1_4seq1.xml…